Advicenne (STU:3MM) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:3MM Advicenne SA STU:3MM
53 GF Score
Price €1.69
GF Value €2.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Advicenne Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:3MM
53GF Score
Advicenne SA STU:3MM
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Advicenne (STU:3MM) Overvalued in 2026?

Based on GuruFocus' analysis, Advicenne stock appears to be undervalued. The current stock price of €1.69 is trading 16.1% below its estimated GF Value™ of €2.01. GuruFocus considers Advicenne to be Modestly Undervalued.

Key valuation signals for STU:3MM:

  • Dividends Received:
  • GF Value™: €2.01 vs. price of €1.69 (16.1% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the STU:3MM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advicenne Business Description

Other Exchanges ALDVI:France3MM:Germany
Address 2, rue Briconnet, Nimes, FRA, F-30 000
Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.
53GF Score

Get the complete analysis for STU:3MM

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.69
Price
€2.01
GF Value